Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel vs Gemcitabine in Advanced Squamous NSCLC
NCT01236716Phase 2Completed
- Sponsor
- Chinese Society of Lung Cancer
- Start
- Nov 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in squamous cell carcinoma of the lung (SCCL), sponsored by Chinese Society of Lung Cancer. Started Nov 2010; status: completed.
02
Drugs
paclitaxel
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT01236716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01236716.